AMAG Pharma (AMAG) Reports Q1 Loss Per Share of $1.59, Raises FY Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. BA
7. SPY
8. INTC
9. JBLU
10. HOOD

Go back to AMAG Pharma (AMAG) Reports Q1 Loss Per Share of $1.59, Raises FY Revenue Guidance

AMAG Pharmaceuticals Announces First Quarter 2018 Financial Results and Raises Full Year Financial Guidance

May 3, 2018 7:00 AM EDT

Strong first quarter execution with two FDA approvals and submission of a new drug application

Conference call scheduled for 8:00 a.m. ET today

WALTHAM, Mass., May 03, 2018 (GLOBE NEWSWIRE) --  AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today reported unaudited consolidated financial results for the quarter ended March 31, 2018, provided a business update, and increased its full year 2018 financial guidance.

Total GAAP revenue for the first quarter of 2018 increased to $146.4 million, 5% higher than the same period last year. The year-over-year increase was driven by the addition of... More